E-Mail
IMAGE: Image of the Bull Run River that feeds the Occoquan Reservoir, an important source of water supply to Fairfax Water, a water utility serving about 2 million people in Northern. view more
Credit: Virginia Tech
Water touches virtually every aspect of human society, and all life on earth requires it. Yet, fresh, clean water is becoming increasingly scarce one in eight people on the planet lack access to clean water. Drivers of freshwater salt pollution such as de-icers on roads and parking lots, water softeners, and wastewater and industrial discharges further threaten freshwater ecosystem health and human water security.
One in four Americans say they don’t want a coronavirus vaccine. That’s according
to a recent poll by NPR and Marist. Misinformation could be one cause, including posts and stories that are shared on social media.
Researchers at Virginia Tech are looking at how this is playing out with people in Appalachia. It’s called, “Trust in Healthcare and
The researchers asked a group of Appalachians who they trusted the most from a list of 15 healthcare-related choices. According to Dr. Michelle Rockwell, lead investigator on the project, most people surveyed said they trusted a primary care doctor.
“We are interested in knowing if there are any subtle interventions that a healthcare provider or healthcare organization could take to help with the spread of misinformation,” Rockwell said. “We designed a social media simulation based on some other work that has shown that little nudges, thinking through accuracy, before reading, social media can make a difference in how tha
Candidate coronavirus vaccines show promising results in early animal testing
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV).
The researchers have recently published their findings in the
Proceedings of the National Academy of Sciences.
The candidate vaccine was developed using an innovative vaccine platform targeting a highly conserved genomic region of coronaviruses. The new vaccine platform utilizes a genome-reduced bacteria to express the coronavirus vaccine antigen on its surface. Such a vaccine platform can be manufactured with low cost in existing facilities around the world, which could meet the pandemic demand.
E-Mail
IMAGE: X.J. Meng, University Distinguished Professor in the Virginia-Maryland College of Veterinary Medicine and founding director of the new center tackling infectious disease in the Fralin Life Sciences Institute at Virginia. view more
Credit: Virginia Tech
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV).
The researchers have recently published their findings in the